Maarten van den Berge Selected Research

COVID-19

1/2022	Timely administration of tocilizumab improves outcome of hospitalized COVID-19 patients.
1/2022	Moxidectin and Ivermectin Inhibit SARS-CoV-2 Replication in Vero E6 Cells but Not in Human Primary Bronchial Epithelial Cells.
10/2021	Resveratrol and Pterostilbene Inhibit SARS-CoV-2 Replication in Air-Liquid Interface Cultured Human Primary Bronchial Epithelial Cells.
6/2021	Multi-omics highlights ABO plasma protein as a causal risk factor for COVID-19.
12/2020	Gene expression network analysis provides potential targets against SARS-CoV-2.
11/2020	ACE inhibition and cardiometabolic risk factors, lung ACE2 and TMPRSS2 gene expression, and plasma ACE2 levels: a Mendelian randomization study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Maarten van den Berge Research Topics

Disease

85	Chronic Obstructive Pulmonary Disease (COPD) 03/2024 - 10/2004
63	Asthma (Bronchial Asthma) 02/2024 - 10/2004
28	Inflammation (Inflammations) 12/2022 - 10/2004
9	Obstructive Lung Diseases (Obstructive Lung Disease) 01/2023 - 11/2012
7	Emphysema 12/2023 - 04/2016
6	COVID-19 01/2022 - 11/2020
6	Airway Remodeling 01/2022 - 01/2016
4	Lung Diseases (Lung Disease) 01/2021 - 04/2016
3	Respiratory Hypersensitivity 01/2022 - 12/2018
3	Pneumonia (Pneumonitis) 12/2021 - 01/2016
2	Infections 03/2024 - 10/2021
2	Necrosis 01/2018 - 08/2014
1	Respiratory Syncytial Virus Infections 02/2024
1	Cystic Fibrosis (Mucoviscidosis) 01/2024
1	Allergic Rhinitis 01/2024
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2024
1	Mitochondrial Diseases (Mitochondrial Disease) 10/2022
1	Neuromuscular Diseases (Neuromuscular Disease) 03/2022
1	Cough 02/2021

Drug/Important Bio-Agent (IBA)

29	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2023 - 02/2010
23	Biomarkers (Surrogate Marker)IBA 12/2023 - 05/2013
15	Proteins (Proteins, Gene)FDA Link 02/2024 - 08/2013
14	SmokeIBA 10/2022 - 08/2013
11	RNA (Ribonucleic Acid)IBA 02/2024 - 01/2020
10	MicroRNAs (MicroRNA)IBA 01/2022 - 01/2017
8	SteroidsIBA 06/2023 - 03/2013
8	Messenger RNA (mRNA)IBA 01/2020 - 08/2013
7	CytokinesIBA 11/2023 - 08/2013
7	Bronchodilator Agents (Bronchodilators)IBA 11/2022 - 03/2014
7	GoldIBA 10/2022 - 01/2014
7	Fluticasone (Cutivate)FDA LinkGeneric 12/2019 - 06/2012
6	Budesonide (Pulmicort)FDA LinkGeneric 01/2023 - 10/2012
4	AllergensIBA 01/2024 - 12/2019
4	Receptor for Advanced Glycation End ProductsIBA 12/2022 - 04/2019
4	Adenosine (Adenocard)FDA LinkGeneric 01/2019 - 01/2007
3	Antiviral Agents (Antivirals)IBA 02/2024 - 10/2021
3	Interleukin-33IBA 12/2023 - 01/2021
3	MucinsIBA 01/2023 - 01/2019
3	Formoterol Fumarate (Oxis)FDA Link 01/2023 - 10/2020
3	Indicators and Reagents (Reagents)IBA 01/2022 - 10/2014
3	LigandsIBA 12/2021 - 08/2013
3	GlucocorticoidsIBA 11/2015 - 12/2011
2	Interleukin-6 (Interleukin 6)IBA 12/2023 - 01/2021
2	Fluticasone-Salmeterol Drug Combination (Advair)FDA Link 01/2023 - 11/2012
2	Muscarinic AntagonistsIBA 01/2022 - 07/2021
2	Tiotropium Bromide (Spiriva)FDA Link 01/2022 - 07/2015
2	Glycopyrrolate (Glycopyrronium Bromide)FDA LinkGeneric 01/2022 - 07/2021
2	ChemokinesIBA 12/2021 - 01/2020
2	Protein Isoforms (Isoforms)IBA 04/2021 - 01/2020
2	Methacholine Chloride (Methacholine)FDA Link 01/2021 - 01/2017
2	ParaquatIBA 01/2021 - 01/2020
2	Small Cytoplasmic RNAIBA 01/2021 - 12/2020
2	Interleukin-13IBA 01/2021 - 07/2015
2	Serine Proteases (Serine Protease)IBA 12/2020 - 11/2020
2	Angiotensin-Converting Enzyme 2IBA 12/2020 - 11/2020
2	Immunoglobulin E (IgE)IBA 01/2020 - 01/2011
2	Adenosine Monophosphate (AMP)IBA 01/2019 - 10/2004
2	PowdersIBA 01/2019 - 01/2017
2	GasesIBA 09/2017 - 04/2016
2	Syntex adjuvant formulationIBA 04/2016 - 09/2014
2	Advanced Glycation End ProductsIBA 04/2016 - 09/2014
2	IntegrasesIBA 04/2016 - 01/2016
1	VaccinesIBA 03/2024
1	Respiratory Syncytial Virus VaccinesIBA 03/2024
1	InterferonsIBA 02/2024
1	Interferon Type IIBA 02/2024
1	RNA Splicing FactorsIBA 02/2024
1	AlarminsIBA 01/2024
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 07/2023
1	Biosimilar PharmaceuticalsIBA 06/2023
1	TinIBA 03/2023
1	Chloride Channels (Chloride Channel)IBA 01/2023
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2023
1	Sodium Channels (Sodium Channel)IBA 01/2023
1	naphthaleneIBA 07/2022
1	Oxygen (Dioxygen)IBA 01/2022
1	HLA-DQB1 antigen (HLA DQB1)IBA 01/2022
1	GSK573719IBA 01/2022
1	Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA 01/2022
1	moxidectinIBA 01/2022
1	Ivermectin (Mectizan)FDA Link 01/2022
1	tocilizumab (atlizumab)FDA Link 01/2022
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 12/2021
1	Transcription Factors (Transcription Factor)IBA 12/2021
1	TNF Receptor-Associated Factor 6 (TRAF6)IBA 12/2021
1	ResveratrolIBA 10/2021
1	pterostilbeneIBA 10/2021
1	AntioxidantsIBA 10/2021
1	budesonide-glycopyrrolate-formoterol fumarate drug combinationIBA 07/2021
1	Blood Proteins (Serum Proteins)IBA 06/2021
1	CollagenIBA 04/2021
1	AnkyrinsIBA 02/2021
1	Histamine (Histamine Dihydrochloride)FDA Link 02/2021
1	O-(glucuronic acid 2-sulfate)-(1--3)-O-(2,5)-andydrotalitol 6-sulfateIBA 01/2021

Therapy/Procedure

17	Therapeutics 01/2024 - 05/2013
1	Ambulatory Care (Outpatient Care) 03/2024
1	Precision Medicine 07/2023
1	Biological Therapy 01/2023
1	Critical Care (Surgical Intensive Care) 03/2022
1	Metered Dose Inhalers (Metered Dose Inhaler) 07/2021